Regen BioPharma (RGBP) Return on Assets (2016 - 2025)
Historic Return on Assets for Regen BioPharma (RGBP) over the last 12 years, with Q4 2025 value amounting to 2.97%.
- Regen BioPharma's Return on Assets rose 29300.0% to 2.97% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.97%, marking a year-over-year increase of 29300.0%. This contributed to the annual value of 5.85% for FY2025, which is 32500.0% down from last year.
- Per Regen BioPharma's latest filing, its Return on Assets stood at 2.97% for Q4 2025, which was up 29300.0% from 5.41% recorded in Q3 2025.
- Regen BioPharma's 5-year Return on Assets high stood at 0.22% for Q2 2021, and its period low was 5.89% during Q4 2024.
- Moreover, its 5-year median value for Return on Assets was 2.12% (2023), whereas its average is 2.47%.
- Its Return on Assets has fluctuated over the past 5 years, first surged by 106800bps in 2021, then tumbled by -43000bps in 2024.
- Regen BioPharma's Return on Assets (Quarter) stood at 0.45% in 2021, then plummeted by -271bps to 1.68% in 2022, then grew by 5bps to 1.6% in 2023, then plummeted by -269bps to 5.89% in 2024, then skyrocketed by 50bps to 2.97% in 2025.
- Its Return on Assets was 2.97% in Q4 2025, compared to 5.41% in Q3 2025 and 5.31% in Q2 2025.